
CytoDyn (OTC: CYDY) Receives Institutional Review Board Approval to Initiate Phase 2 Basket Trial for 22 Solid Tumor Cancers
VANCOUVER, Washington, Feb 21, 2020 — Results from mTNBC and MBC studies continues to be positive with the first patient now at almost five months of treatment showing zero CTC, EMT and CAML. Seven patients […]